Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder Medical Device Investing
Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference Medical Device Investing
Pulse Biosciences' nPulse Vybrance System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting Medical Device Investing
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook Medical Device Investing
Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology Life Science Investing
Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach Life Science Investing
